An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score

被引:453
|
作者
Stewart, WF
Lipton, RB
Whyte, J
Dowson, A
Kolodner, K
Liberman, JN
Sawyer, J
机构
[1] Innovat Med Res, Towson, MD USA
[2] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Dept Social Med, Bronx, NY 10467 USA
[6] Zeneca Pharmaceut, Alderley Pk, England
[7] Kings Coll Hosp London, London, England
关键词
migraine disability; headache pain severity;
D O I
10.1212/WNL.53.5.988
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Migraine Disability Assessment (MIDAS) instrument is a five-item questionnaire developed to measure headache-related disability and improve doctor-patient communication about the functional consequences of migraine. Objectives: To examine the test-retest reliability and internal consistency of the five items and of the overall MIDAS score in population-based samples of migraine sufferers in two countries and to compare consistency across countries. Methods: Using a clinically validated telephone interview, population-based samples of migraine-headache sufferers were identified in the United States (Baltimore, MD) and the United Kingdom (Merton and Sutton, Surrey). Eligible individuals completed the MIDAS questionnaire on two occasions an average of 3 weeks apart. The MIDAS score is derived from five questions about missed time from work and household work (one question each about missed days and days with at least 50% reduced productivity) and missed days of nonwork activities. Results: A total of 97 migraine-headache sufferers from the United States and 100 from the United Kingdom completed the MIDAS questionnaire twice. Mean and median item values and overall MIDAS scores were similar between the United States and the United Kingdom. Test-retest Spearman correlations of individual items ranged from 0.46 to 0.78, No significant differences in item-specific correlations were observed between the United States and United Kingdom. The test-retest Pearson correlation of the MIDAS score (i.e., sum of lost days and reduced-effectiveness days in each domain) was 0.80 in the United States and 0.83 in the United Kingdom. The Cronbach alpha, a measure of internal consistency, was 0.76 in the United States and 0.73 in the United Kingdom. Conclusions: This is the first international population-based study to assess the reliability of a disability-related illness severity score for migraine. The reliability and internal consistency of the Migraine Disability Assessment score are similar to that of a previous questionnaire (Headache Impact Questionnaire), However, the Migraine Disability Assessment score requires fewer questions, is easier to score, and provides intuitively meaningful information on lost days of activity in three domains.
引用
收藏
页码:988 / 994
页数:7
相关论文
共 50 条
  • [41] EHMTI-0132. Premonitory symptoms and migraine disability assessment (MIDAS) questionnaire
    S Sretenovic
    A Stanic
    A Mitrovic
    [J]. The Journal of Headache and Pain, 2014, 15
  • [42] DISABILITY IMPROVEMENTS OVER 12 MONTHS WITH LASMIDITAN FOR ACUTE TREATMENT OF MIGRAINE: INTERIM ANALYSIS OF MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCALE CHANGES IN THE GLADIATOR STUDY
    Lipton, R. B.
    Lombard, L.
    Ruff, D. D.
    Nichols, R. M.
    Krege, J. H.
    [J]. CEPHALALGIA, 2018, 38 : 141 - 142
  • [43] Thai-version Migraine Disability Assessment (MIDAS) questionnaire: concurrent validity, test-retest reliability, internal consistency, and factors predictive for migraine-related disability
    Asawavichienjinda, Thanin
    Imruetaijaroenchoke, Warangkana
    Phanthumchinda, Kammant
    [J]. ASIAN BIOMEDICINE, 2020, 14 (04) : 139 - 150
  • [44] The MIDAS questionnaire:: disability evaluation in migraine patients
    Pascual-Lozano, AM
    Láinez-Andrés, JM
    [J]. REVISTA DE NEUROLOGIA, 2004, 38 (09) : 898 - 898
  • [45] CHARACTERISTICS OF MIGRAINE PATIENTS WITH MIGRAINE DISABILITY ASSESSMENT (MIDAS) SCORES IN REAL-WORLD CLINICAL PRACTICE
    Chia, V. M.
    Thach, A.
    Yusuf, A.
    Kallenbach, L.
    Bogdanov, A.
    [J]. VALUE IN HEALTH, 2019, 22 : S286 - S286
  • [46] Potential of the Migraine Disability Assessment (MIDAS) Questionnaire as a public health initiative and in clinical practice
    Edmeads, J
    Láinez, JM
    Brandes, JL
    Schoenen, J
    Freitag, F
    [J]. NEUROLOGY, 2001, 56 (06) : S29 - S34
  • [47] Effect of Migraine Headache on Productivity of Patients According to Migraine Disability Assessment Score: A Cross-Sectional Study
    Jawed, Shafaq
    Ali, Waqar
    Yaqoob, Uzair
    Shah, Shahnaz
    Uddin, Syed Mohammad Mazhar
    Haq, Aatera
    [J]. PAIN AND THERAPY, 2019, 8 (02) : 233 - 238
  • [48] The Paediatric migraine disability assessment score is a useful tool for evaluating prophylactic migraine treatment
    Topcu, Yasemin
    Kurul, Semra Hiz
    Bayram, Erhan
    Sozmen, Kaan
    Yis, Uluc
    [J]. ACTA PAEDIATRICA, 2014, 103 (11) : E484 - E489
  • [49] Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment
    Pedro L. Ferreira
    Isabel Luzeiro
    Margarida Lopes
    André Jorge
    Bruno Silva
    Lara Ferreira
    [J]. BMC Neurology, 21
  • [50] Validity and reliability of the Portuguese version of the modified Migraine Disability Assessment
    Ferreira, Pedro L.
    Luzeiro, Isabel
    Lopes, Margarida
    Jorge, Andre
    Silva, Bruno
    Ferreira, Lara
    [J]. BMC NEUROLOGY, 2021, 21 (01)